search button
Open Access

miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression

  • Authors:
    • Xueyan Wen
    • Songrong Li
    • Mengchan Guo
    • Hongzhan Liao
    • Yongmin Chen
    • Xi Kuang
    • Xiaoping Liao
    • Lin Ma
    • Qifu Li

  • View Affiliations

  • Published online on: September 14, 2020     https://doi.org/10.3892/ol.2020.12098
  • Article Number: 235

  • Copyright: © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioblastoma (GBM) is the most common malignant primary tumor in the human central nervous system. The present study aimed to explore the molecular mechanism by which microRNA (miR)‑181a‑5p targets the F‑box protein 11 (FBXO11) in glioma cells to inhibit cell proliferation and invasion. Reverse transcription‑quantitative (RT‑q)PCR was performed to detect the expression levels of miR‑181a‑5p in U251TR cells, U251 cells, primary GBM tissues and relapsed GBM tissues in order to determine the association between miR‑181a‑5p and the chemoresistance of GBM cells. The expression levels of miR‑181a‑5p in GBM cells were modulated via transfecting miR‑181a‑5p mimics and inhibitors. Cell Counting Kit‑8 assays were undertaken to assess the effects of miR‑181a‑5p on drug sensitivity and proliferation of GBM cells. Wound healing assays were performed to examine the effects of miR‑181a‑5p on the migratory ability of GBM cells. Furthermore, the effects of miR‑181a‑5p on the invasive ability of GBM cells were analyzed using an in vitro invasion assay. Flow cytometry analysis was carried out to determine whether overexpression of miR‑181a‑5p can promote the apoptotic rate of GBM cells. RT‑qPCR and western blotting were employed to detect the effects of miR‑181a‑5p on mRNA and protein expression of FBX011. miR‑181a‑5p exhibited low expression in resistant GBM cell lines and recurrent tumor tissues. Dual‑luciferase reporter assays were utilized to detect luciferase activity to verify the targeted regulatory association between miR‑181a‑5p and FBXO11. Upregulation of miR‑181a‑5p promoted the sensitivity of GBM cells to temozolomide (TMZ), increased the apoptotic rate of GBM cells and significantly inhibited the invasive and migratory capacities of GBM cells. In drug‑resistant glioma cells, compared with the miR‑negative control group and the blank group, the expression of miR‑181a‑5p was significantly upregulated (P<0.01), while the expression of FBXO11 protein was downregulated. miR‑181a‑5p increased the sensitivity of GBM cells to TMZ. miR‑181a‑5p significantly inhibited the migratory and invasive capacities of GBM cells. miR‑181a‑5p may become a novel effective target for the treatment of GBM. The results of dual‑luciferase reporter assays indicated that miR‑181a‑5p could target the 3'‑untranslated region of FBXO11. The underlying mechanism may be targeted inhibition of FBXO11 gene expression, or may be associated with apoptosis.
View Figures
View References

Related Articles

Journal Cover

November-2020
Volume 20 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Wen X, Li S, Guo M, Liao H, Chen Y, Kuang X, Liao X, Ma L and Li Q: miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression. Oncol Lett 20: 235, 2020
APA
Wen, X., Li, S., Guo, M., Liao, H., Chen, Y., Kuang, X. ... Li, Q. (2020). miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression. Oncology Letters, 20, 235. https://doi.org/10.3892/ol.2020.12098
MLA
Wen, X., Li, S., Guo, M., Liao, H., Chen, Y., Kuang, X., Liao, X., Ma, L., Li, Q."miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression". Oncology Letters 20.5 (2020): 235.
Chicago
Wen, X., Li, S., Guo, M., Liao, H., Chen, Y., Kuang, X., Liao, X., Ma, L., Li, Q."miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression". Oncology Letters 20, no. 5 (2020): 235. https://doi.org/10.3892/ol.2020.12098